Where does Zymeworks Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Zymeworks Inc. ranks #6,209 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Zymeworks Inc. hold?

Zymeworks Inc. holds 55 US utility patents granted between 2015 and 2023, spanning 17 technology areas.

What is Zymeworks Inc.'s Innovation Score?

Zymeworks Inc. has an Innovation Score of 44.8 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Zymeworks Inc. focus on?

Zymeworks Inc.'s top technology area is C07K (Peptides) with 45 patents, ranking #207 of 3,615 assignees active in that subclass. Grants appear in 17 CPC subclasses total.

Is Zymeworks Inc.'s patent grant rate increasing or decreasing?

Zymeworks Inc.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Zymeworks Inc.'s patents?

Zymeworks Inc.'s patents average 27.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Zymeworks Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Zymeworks Inc.

USPTO PatentsView assignee record - 55 granted patents across 17 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Zymeworks ranks #6,209 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 17 technology areas.

#6,209
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.8/100): 27.5
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6209 · Foreign Corporation #6,209 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,209/49,997
PHOTO-FINISH iCometrue
CPC-FOCUS C07K · 17 areas
INNOV-PAR 44.8/100
CLAIMS-DENSE 27.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: iCometrue Company Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Zymeworks’s 44.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (31%) Velocity 1.3 pts (3%) Breadth 14.6 pts (33%) Claim depth 15.0 pts (33%)

Qualcomm Incorporated · highest

85
Eagle View · near

45
IHI Aerospace · near

45
Prinsco · near

45
Telepathy Labs · near

45
Zymeworks · this assignee

45
3D Lighting… · lowest

7

What this shows Zymeworks's Innovation Score is 44.8/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Zymeworks?

Each dot is one of Zymeworks’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zymeworks’s own 27.5 claims/patent is ABOVE the 11.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Zymeworks vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Zymeworks's grants concentrate

Zymeworks Inc. is a focused PatentsView assignee: 17 CPC subclasses with 81.8% of grants classified under C07K (Peptides). Peak complete grant year is 2019 (14 grants) versus a trough of 1 in 2015. By volume, Zymeworks sits between W Schonbek LLC and Amlogic (SHANGHAI) Co., Ltd..

Zymeworks's three-year grant acceleration

From 2019–2021 to 2022–2024, Zymeworks Inc. moved from 30 to 6 grants (0.20x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

W Schonbek

55
Wieland-werke

55
Whitmor

55
Youcopia Products

55
Zeta Global

55
icometrue

55
Zymeworks ◀

55
3DT Holdings

54
Amlogic (Shanghai)

54

What this shows Zymeworks holds 55 patents at rank #6,207, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Zymeworks

By rank, the assignees closest to #6,207 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Zymeworks's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Zymeworks, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Zymeworks ranks #207 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Eagle View Technologies, Inc. 45 IHI Aerospace Co., Ltd. 45 Telepathy Labs, Inc. 45 Prinsco, Inc. 45

Similar claim depth

Nearest assignees by average claims per patent (27.5 here).

Alfred KÄRCHER SE & Co. KG 27.6 avg Augustine Biomedical + Design, LLC 27.6 avg Semmle Limited 27.4 avg BCE Inc. 27.6 avg

Zymeworks's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Zymeworks Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.8%
2016	6	10.9%
2017	5	9.1%
2018	7	12.7%
2019	14	25.5%
2020	4	7.3%
2021	12	21.8%
2022	5	9.1%
2023	1	1.8%

Which technologies does Zymeworks Inc. patent most?

C07K - Peptides 45

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 37

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C07D - Heterocyclic Compounds 5

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 5

G06F - Electric Digital Data Processing 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

H10K - Organic Electric Solid-state Devices 3

H01L - Semiconductor Devices NOT Covered BY Class H10 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

C12Y - Enzymes 3

C07C - Acyclic OR Carbocyclic Compounds 2

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Zymeworks Inc.'s patent record in context - here's where to go next.

Zymeworks Inc.'s lead technology class is C07K (Peptides), 81.8% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #6,209 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Zymeworks Inc. against W Schonbek LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.